Journal profile · Medicine-Pathology and Forensic Medicine

Journal of the American Society of Cytopathology

ISSN 2213-2945 · eISSN 2213-2953 · Elsevier

Journal of the American Society of Cytopathology: impact factor 2.7 (journal website); hybrid open access; APC about USD 3,050; median 60 days to acceptance (97 articles, last 24 months); 176 articles in 2025; indexed in ESCI and Scopus.

Impact factor2.7From the journal's website, latest value
CAS zone—Not in the CAS Journal Ranking
Review time60 daysMedian, submission to acceptance · 97 articles, last 24 months · PubMed
APCUSD 3,050Hybrid journal: charged only for open-access articles
Acceptance—No reports yet
Articles per year1762025 · OpenAlex count

Scope

Aims, scope and focus

Journal of the American Society of Cytopathology is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Cervical Cancer and HPV Research, Thyroid Cancer Diagnosis and Treatment and Pancreatic and Hepatic Oncology Research, together about 31% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

JASC is the official journal of the American Society of Cytopathology,and reflects the values and priorities of the society. JASC publishes regular bimonthly issues with cutting-edge original research of the highest standard. The Journal seeks to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal ensures the sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines.JASC endeavors to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC publishes original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference is also given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. It duly addresses and highlights issues relating to population health and public policy topics. It is the goal of JASC to lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Pathology and Forensic Medicine

Editor-in-chief Paul VanderLaanPublisher website

Editorial board by country: none in mainland China; most named United States 95, Canada 3, Australia 3, United Kingdom 2, Hong Kong, China 1 (111 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cervical Cancer and HPV ResearchMedicine15.5%
  2. Thyroid Cancer Diagnosis and TreatmentMedicine8.2%
  3. Pancreatic and Hepatic Oncology ResearchMedicine7.3%
  4. AI in cancer detectionComputer Science6.2%
  5. Lung Cancer Diagnosis and TreatmentMedicine6%
  6. Salivary Gland Tumors Diagnosis and TreatmentMedicine5.6%
  7. Head and Neck Cancer StudiesMedicine4.6%
  8. Lung Cancer Treatments and MutationsMedicine3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
2.7Publisher website ·
CiteScore 2026-06
4.6LetPub ·
CiteScore (publisher)
4.6Publisher website ·
SJR 2026-06
0.68LetPub ·
SNIP 2026-06
1.18LetPub ·
h-index
33OpenAlex ·
i10-index
230OpenAlex ·
2-year mean citedness
0.63OpenAlex ·
Self-citation rate
7.4%LetPub ·
Share of gold OA articles
12.5%LetPub ·

Volume

Articles per year
40LetPub ·

Articles by year OpenAlex count · 3,574 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261791255
20251761983
202419223259
20232106676
202221821498
202121022469

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

60 daysMedian, submission to acceptance · P25–P75 44 days – 83 days

Acceptance to online
median 6 days (97 articles)
Submission to online
median 66 days
Sample
97 articles with submission and acceptance dates (119 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Submission to first decision
2 daysPublisher website ·
First decision after review
23 daysPublisher website ·
Submission to acceptance
60 daysPublisher website ·
Acceptance to publication
6 daysPublisher website ·
Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,050 / EUR 2,850 / GBP 2,440 / JPY 378,290——
Publisher websiteUSD 3,550——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
≤ 250 words
Keywords
≥ 5
Reference style
AMA
First submission
Free format: the journal's layout is not required
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted5, with length limits
  1. annual meeting abstractsSubmissions to the American Society of Cytopathology Annual Scientific Meeting abstract book must contain the following elements: Introduction; Materials and Me…Length not stated
  2. book reviewsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
  3. current topicsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
  4. editorialsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
  5. letters to the editorJournal of the American Society of Cytopathology encourages Letters to the Editor, which will be published at the discretion of the editor as space permits and …main text ≤ 500 words · references ≤ 5
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
AI use Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Source ↗Publisher website ·
Authorship Group authorship

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

Source ↗Publisher website ·
Conflicts of interest Declaration of competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

Source ↗Publisher website ·
Publication ethics

Ethics in publishing Model summary

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Source ↗Publisher website ·
License & copyright License options

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

Source ↗Publisher website ·
Open access Open access

We refer you to our open access information page to learn about open access options for this journal.

Source ↗Publisher website ·
Peer review Peer review

Single anonymized review process Model summary

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

Source ↗Publisher website ·
Preprints Preprints

Preprint sharing allowed Model summary

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier
ISSN
2213-2945
Electronic ISSN
2213-2953
Society / sponsor
American Society of Cytopathology
Official links

FAQ

Frequently asked questions about Journal of the American Society of Cytopathology

What is the impact factor of Journal of the American Society of Cytopathology?

The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.6, h-index 33.

How long does peer review take at Journal of the American Society of Cytopathology?

Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 44–83 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Journal of the American Society of Cytopathology?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 5; Reference style: AMA; First submission: Free format: the journal's layout is not required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Journal of the American Society of Cytopathology based?

Of the 111 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (95), Canada (3) and Australia (3). Counted from the institutions listed on the board page; for reference only.

Which databases index Journal of the American Society of Cytopathology?

According to LetPub and DOAJ records, Journal of the American Society of Cytopathology is indexed in ESCI and Scopus.

Is Journal of the American Society of Cytopathology open access, and what is the APC?

Journal of the American Society of Cytopathology is a hybrid journal. For open-access publication: APC about USD 3,050.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .